Skip to content
Disclosery

QIMING U.S. VENTURES MANAGEMENT, LLC

Follow

13F filer, CIK 1909617, BELLEVUE, WA

QIMING U.S. VENTURES MANAGEMENT, LLC reported $51,146,718 across 6 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-01-28.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-006699

Period
2024-12-31
Reported value
$51.1M
Holdings
6
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KZRnew+82,871$557K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KEZAR LIFE SCIENCES INCexited-828,711-$638K
HILLEVAX INCreduced-186,308-$386K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001104659-25-006699, largest first. % of portfolio is the value over $51,146,718, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: 928,964 shares; 2024Q2: 928,964 shares; 2024Q3: 928,964 shares; 2024Q4: 928,964 shares 928,964$19.9M38.83%0Timeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 641,691 shares; 2024Q1: 741,691 shares; 2024Q2: 741,691 shares; 2024Q3: 741,691 shares; 2024Q4: 741,691 shares 741,691$15M29.41%0
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 368,085 shares; 2024Q1: 368,085 shares; 2024Q2: 368,085 shares; 2024Q3: 368,085 shares; 2024Q4: 368,085 shares 368,085$14M27.4%0Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 686,370 shares; 2024Q1: 412,225 shares; 2024Q2: 412,225 shares; 2024Q3: 412,225 shares; 2024Q4: 412,225 shares 412,225$903K1.77%0Timeline
HILLEVAX INCHILLEVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 558,923 shares; 2024Q1: 558,923 shares; 2024Q2: 558,923 shares; 2024Q3: 558,923 shares; 2024Q4: 372,615 shares 372,615$771K1.51%-186,308
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 82,871 shares 82,871$557K1.09%newTimeline

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
KEZAR LIFE SCIENCES INCKEZAR LIFE SCIENCES INC828,711$638Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-25-006699 base2025-01-28acceptance time not in the bulk data set